SHORT JAY M PHD

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$531,667.77
Insider Sells Quantity
13
Insider Sells Sum
$21.59M

Insider Activity of SHORT JAY M PHD

The largest purchase of all time was on 2022-08-12 and amounted to 26350 shares of BioAtla, Inc. for $206,600.

The largest sale of all time was on 2021-06-14 and amounted to 2463001 share of BioAtla, Inc. for $6.37M.

Biography of SHORT JAY M PHD

No biography is available at this moment.

2023-12-20PurchaseBioAtla, Inc.
BCAB
Chief Executive Officer
50,000
0.1107%
$2.14$106,910+1.47%
2023-03-29PurchaseBioAtla, Inc.
BCAB
Chief Executive Officer
40,800
0.0845%
$2.47$100,862+1.79%
2022-08-12PurchaseBioAtla, Inc.
BCAB
Chief Executive Officer
26,350
0.0788%
$7.84$206,600-46.78%
2022-06-21PurchaseBioAtla, Inc.
BCAB
Chief Executive Officer
40,308
0.114%
$2.91$117,296+40.73%
2021-12-02SaleBioAtla, Inc.
BCAB
Chief Executive Officer
4,811
0.0135%
$21.76$104,666-70.68%
2021-12-01SaleBioAtla, Inc.
BCAB
Chief Executive Officer
24,321
0.0763%
$23.03$560,226-69.08%
2021-11-30SaleBioAtla, Inc.
BCAB
Chief Executive Officer
18,490
0.0533%
$24.51$453,154-73.31%
2021-11-29SaleBioAtla, Inc.
BCAB
Chief Executive Officer
15,435
0.046%
$23.89$368,742-71.7%
2021-11-24SaleBioAtla, Inc.
BCAB
Chief Executive Officer
17,022
0.0489%
$24.87$423,314-73.81%
2021-11-23SaleBioAtla, Inc.
BCAB
Chief Executive Officer
40,804
0.1181%
$24.67$1.01M-73.38%
2021-11-22SaleBioAtla, Inc.
BCAB
Chief Executive Officer
31,350
0.0946%
$26.23$822,467-73.9%
2021-08-24SaleBioAtla, Inc.
BCAB
Chief Executive Officer
12,280
0.023%
$26.71$328,019-82.15%
2021-06-21SaleBioAtla, Inc.
BCAB
Chief Executive Officer
110,000
0.3357%
$39.13$4.3M-47.43%
2021-06-17SaleBioAtla, Inc.
BCAB
Chief Executive Officer
38,538
0.1169%
$39.22$1.51M-47.24%
2021-06-16SaleBioAtla, Inc.
BCAB
Chief Executive Officer
70,834
0.2121%
$39.41$2.79M-46.89%
2021-06-15SaleBioAtla, Inc.
BCAB
Chief Executive Officer
64,046
0.1905%
$39.71$2.54M-46.85%
2021-06-14SaleBioAtla, Inc.
BCAB
Chief Executive Officer
2.46M
0.4741%
$2.59$6.37M-47.14%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.